|
|
||||||||
The Journal of Immunology, Vol 155, Issue 12 5711-5718, Copyright © 1995 by American Association of Immunologists
ARTICLES |
Z Melkova and M Esteban
Department of Biochemistry, Health Science Center at Brooklyn, NY.
Nitric oxide (NO) exerts multiple biologic roles in animal cells through differential regulation of three distinct forms of NO synthase encoded by separate genes. Macrophage-inducible nitric oxide synthase (iNOS) has been correlated with inhibition of viral growth, but little is known about the mechanism of this effect. To study the antiviral role of NO, we have generated a vaccinia virus (VV) recombinant expressing iNOS under the control of Escherichia coli LacI operator/repressor elements. When cultured cells of various origins are infected with this recombinant virus, there is inducible expression of iNOS in the presence of isopropylthio-beta-galactoside, as determined by Western blot and by detection of nitrite, a NO oxidation product. The levels of nitrite increase with time after infection, correlating with marked inhibition of VV DNA and late protein synthesis. Expression of VV early proteins is not affected by NO. Inhibition of VV DNA synthesis is likely to be in part a consequence of NO-mediated inhibition of viral ribonucleotide reductase, as this inhibition can be partially overcome by addition of deoxyribonucleosides. Inhibition of the essential viral functions by NO results in a reduction of virus yields by 50 to 90%, depending on the cell line. Thus, our results demonstrate a direct antiviral effect of NO, with inhibition of VV replication occurring at the level of DNA synthesis.
This article has been cited by other articles:
![]() |
M. Zhang, J. Zhou, B. Marshall, H. Xin, and S. S. Atherton Lack of iNOS Facilitates MCMV Spread in the Retina Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. UBOL, C. SUKWATTANAPAN, and Y. MANEERAT Inducible nitric oxide synthase inhibition delays death of rabies virus-infected mice J. Med. Microbiol., March 1, 2001; 50(3): 238 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Noda, K. Tanaka, S.-a. Sawamura, M. Sasaki, T. Matsumoto, K. Mikami, Y. Aiba, H. Hasegawa, N. Kawabe, and Y. Koga Role of Nitric Oxide Synthase Type 2 in Acute Infection with Murine Cytomegalovirus J. Immunol., March 1, 2001; 166(5): 3533 - 3541. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Stojdl, N. Abraham, S. Knowles, R. Marius, A. Brasey, B. D. Lichty, E. G. Brown, N. Sonenberg, and J. C. Bell The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus J. Virol., October 15, 2000; 74(20): 9580 - 9585. [Abstract] [Full Text] |
||||
![]() |
D. Blond, H. Raoul, R. Le Grand, and D. Dormont Nitric Oxide Synthesis Enhances Human Immunodeficiency Virus Replication in Primary Human Macrophages J. Virol., October 1, 2000; 74(19): 8904 - 8912. [Abstract] [Full Text] |
||||
![]() |
M. M. Gherardi, J. C. Ramírez, and M. Esteban Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide J. Virol., July 15, 2000; 74(14): 6278 - 6286. [Abstract] [Full Text] |
||||
![]() |
F. Chen, Y. Lu, V. Castranova, Y. Rojanasakul, K. Miyahara, Y. Shizuta, V. Vallyathan, X. Shi, and L. M. Demers Nitric Oxide Inhibits HIV Tat-Induced NF-{kappa}B Activation Am. J. Pathol., July 1, 1999; 155(1): 275 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gherardi, J. C. Ramirez, D. Rodriguez, J. R. Rodriguez, G.-I. Sano, F. Zavala, and M. Esteban IL-12 Delivery from Recombinant Vaccinia Virus Attenuates the Vector and Enhances the Cellular Immune Response Against HIV-1 Env in a Dose-Dependent Manner J. Immunol., June 1, 1999; 162(11): 6724 - 6733. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hori, P. R. Burd, K. Furuke, J. Kutza, K. A. Weih, and K. A. Clouse Human Immunodeficiency Virus-1-Infected Macrophages Induce Inducible Nitric Oxide Synthase and Nitric Oxide (NO) Production in Astrocytes: Astrocytic NO as a Possible Mediator of Neural Damage in Acquired Immunodeficiency Syndrome Blood, March 15, 1999; 93(6): 1843 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bodaghi, O. Goureau, D. Zipeto, L. Laurent, J.-L. Virelizier, and S. Michelson Role of IFN-{gamma}-Induced Indoleamine 2,3 Dioxygenase and Inducible Nitric Oxide Synthase in the Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells J. Immunol., January 15, 1999; 162(2): 957 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Heitmeier, A. L. Scarim, and J. A. Corbett Double-stranded RNA-induced Inducible Nitric-oxide Synthase Expression and Interleukin-1 Release by Murine Macrophages Requires NF-kappa B Activation J. Biol. Chem., June 12, 1998; 273(24): 15301 - 15307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Reiss and T. Komatsu Does Nitric Oxide Play a Critical Role in Viral Infections? J. Virol., June 1, 1998; 72(6): 4547 - 4551. [Full Text] [PDF] |
||||
![]() |
C. Zaragoza, C. Ocampo, M. Saura, M. Leppo, X.-Q. Wei, R. Quick, S. Moncada, F. Y. Liew, and C. J. Lowenstein The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis PNAS, March 3, 1998; 95(5): 2469 - 2474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Sharara, D. J. Perkins, M. A. Misukonis, S. U. Chan, J. A. Dominitz, and J. B. Weinberg Interferon (IFN)-alpha Activation of Human Blood Mononuclear Cells In Vitro and In Vivo for Nitric Oxide Synthase (NOS) Type 2 mRNA and Protein Expression: Possible Relationship of Induced NOS2 to the Anti-Hepatitis C Effects of IFN-alpha In Vivo J. Exp. Med., November 3, 1997; 186(9): 1495 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Heitmeier, M. Arnush, A. L. Scarim, and J. A. Corbett Pancreatic beta -Cell Damage Mediated by beta -Cell Production of Interleukin-1. A NOVEL MECHANISM FOR VIRUS-INDUCED DIABETES J. Biol. Chem., March 30, 2001; 276(14): 11151 - 11158. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |